Bacteriophage with Programmable Antibiotic Activity
Feng Zhang of the Broad Institute of MIT and Harvard in the U.S. proposes to engineer bacterial viruses to deliver enzymes that can be designed to degrade the genome of pathogenic bacteria. These bacteriophages could be used as a new platform for treating drug-resistant bacterial infections.